Trends in the Research Into Immune Checkpoint Blockade by Anti-PD1/PDL1 Antibodies in Cancer Immunotherapy: A Bibliometric Study

The programmed death receptor 1 (PD1) and its ligand programmed death receptor ligand 1 (PDL1) are the most widely used immune checkpoints in cancer immunotherapy. The related literature shows the explosive growth trends due to the promising outcomes of tumor regression. The present study aimed to p...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yiting Sun, Liqing Jiang, Ti Wen, Xiaoyu Guo, Xinye Shao, Hui Qu, Xi Chen, Yujia Song, Fang Wang, Xiujuan Qu, Zhi Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-08-01
coleção:	Frontiers in Pharmacology
Assuntos:	PD1/PDL1 immune checkpoint blockade bibliometrics randomized clinical trials meta-analysis
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2021.670900/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!